Investors who own more than 5% of a class must file a Schedule 13D or 13G. Every filing for 603170101 since 12/18/2024, newest first.
| Filer | % of Class | Filed | |
|---|---|---|---|
|
FMR LLC
13G/A
Amendment 1
|
5.1% |
8/6/2026
Event 6/30/2026
|
|
| FMR LLC | 5.1% | ||
| Abigail P. Johnson | 5.1% | ||
|
Catalys Pacific Fund, LP
13G/A
Amendment 3
|
10.1% |
2/13/2026
Event 12/31/2025
|
|
| Catalys Pacific Fund, LP | 10.1% | ||
| Catalys Pacific Fund GP, LP | 10.1% | ||
| Catalys Pacific, LLC | 10.1% | ||
| Brian Taylor Slingsby | 10.1% | ||
|
FMR LLC
13G
|
6.3% |
2/5/2026
Event 12/31/2025
|
|
| FMR LLC | 6.3% | ||
| Abigail P. Johnson | 6.3% | ||
| BlackRock, Inc. 13G | 5.2% |
1/21/2026
Event 12/31/2025
|
|
|
Samsara BioCapital, L.P.
13D/A
Amendment 3
|
8.2% |
9/8/2025
Event 9/4/2025
|
|
| Samsara BioCapital, L.P. | 7.3% | ||
| Samsara BioCapital GP, LLC | 7.3% | ||
| Samsara Opportunity Fund, L.P. | 0.8% | ||
| Samsara Opportunity Fund GP, LLC | 0.8% | ||
| Srinivas Akkaraju | 8.2% | ||
|
RA Capital Management, L.P.
13D/A
Amendment 3
|
9.9% |
9/8/2025
Event 9/4/2025
|
|
| RA Capital Management, L.P. | 9.9% | ||
| Peter Kolchinsky | 9.9% | ||
| Rajeev Shah | 9.9% | ||
| RA Capital Healthcare Fund, L.P. | 7.5% | ||
|
Andera Partners
13G/A
Amendment 1
|
4.2% |
8/14/2025
Event 6/30/2025
|
|
| Andera Partners | 4.2% | ||
| BioDiscovery 6 FPCI | 4.2% | ||
| Stephane Bergez | 4.2% | ||
| Francois Xavier Mauron | 4.2% | ||
|
Catalys Pacific Fund, LP
13G/A
Amendment 2
|
13.5% |
8/14/2025
Event 6/30/2025
|
|
| Catalys Pacific Fund, LP | 13.5% | ||
| Catalys Pacific Fund GP, LP | 13.5% | ||
| Catalys Pacific, LLC | 13.5% | ||
| Brian Taylor Slingsby | 13.5% | ||
|
Samsara BioCapital, L.P.
13D/A
Amendment 2
|
9.1% |
3/17/2025
Event 3/13/2025
|
|
| Samsara BioCapital, L.P. | 9.0% | ||
| Samsara BioCapital GP, LLC | 9.0% | ||
| Srinivas Akkaraju | 9.1% | ||
|
RA Capital Management, L.P.
13D/A
Amendment 2
|
9.9% |
3/17/2025
Event 3/13/2025
|
|
| RA Capital Management, L.P. | 9.9% | ||
| Peter Kolchinsky | 9.9% | ||
| Rajeev Shah | 9.9% | ||
| RA Capital Healthcare Fund, L.P. | 6.9% | ||
|
Adams Street Partners, LLC
13G/A
Amendment 1
|
2.3% |
2/14/2025
Event 12/31/2024
|
|
| Adams Street Partners, LLC | 2.3% | ||
| Adams Street 2016 Direct Venture/Growth Fund LP | 0.2% | ||
| Adams Street 2017 Direct Venture/Growth Fund LP | 0.2% | ||
| Adams Street 2018 Direct Venture/Growth Fund LP | 0.4% | ||
| Adams Street 2019 Direct Growth Equity Fund LP | 0.2% | ||
| Adams Street 2020 Direct Growth Equity Fund LP | 0.2% | ||
| Adams Street 2021 Direct Growth Equity Fund LP | 0.2% | ||
| Adams Street Growth Equity Fund VII LP | 0.9% |
| Period | Filings | Shares, Excl. Options | Value, Excl. Options |
|---|---|---|---|
| 2026 Q3 | 4 | 1.79 k | $44.9 k |
| 2026 Q2 | 243 | 102 M | $2.78 B |
| 2026 Q1 | 234 | 90.9 M | $2.47 B |
| 2025 Q4 | 243 | 88.4 M | $3.21 B |
| 2025 Q3 | 202 | 79.5 M | $3.01 B |
| 2025 Q2 | 171 | 66.3 M | $897 M |
| 2025 Q1 | 166 | 61.2 M | $972 M |
| 2024 Q4 | 110 | 46.5 M | $572 M |
| 2024 Q3 | 110 | 44.4 M | $540 M |
| 2024 Q2 | 100 | 45.2 M | $529 M |
| 2024 Q1 | 98 | 42.9 M | $554 M |
| 2023 Q4 | 92 | 35.3 M | $304 M |
| 2023 Q3 | 79 | 26.5 M | $252 M |
| 2023 Q2 | 69 | 25.2 M | $429 M |
| 2023 Q1 | 69 | 24.6 M | $386 M |